Determining 'Avoidability' of Nursing Home Transfers Complex

This article originally appeared here.
Share this content:
Determining 'Avoidability' of Nursing Home Transfers Complex
Determining 'Avoidability' of Nursing Home Transfers Complex

MONDAY, March 5, 2018 (HealthDay News) -- A substantial proportion of acute transfers from nursing facilities to hospitals are potentially avoidable, but symptoms and risk conditions are only weakly predictive of hospital diagnoses, according to a study published online Feb. 13 in the Journal of the American Geriatrics Society.

Kathleen T. Unroe, M.D., from Indiana University in Indianapolis, and colleagues assessed the relationship between nursing facility resident risk conditions, signs, and symptoms at time of acute transfer and diagnosis of conditions associated with potentially avoidable acute transfers (pneumonia, urinary tract infection, congestive heart failure [CHF], chronic obstructive pulmonary disease [COPD] or asthma, dehydration, pressure sores). Data were included for 1,174 long-stay nursing facility residents who experienced 1,931 acute transfers from November 2014 to July 2016.

The researchers found that 44 percent of acute transfers were associated with one of six potentially avoidable diagnoses. Symptoms before transfer did not easily differentiate hospital diagnoses, as symptoms mapped into multiple diagnoses. Furthermore, most hospital diagnoses had multiple associated symptoms. For example, among residents with a history of CHF and COPD, more than two-thirds of acute transfers were for reasons other than exacerbations of those conditions.

"Although it is widely recognized that many transfers of nursing facility residents are potentially avoidable, determining 'avoidability' at time of transfer is complex," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »